Simulations Plus Inc (SLP) Com USD0.001

Sell:$35.44Buy:$35.50$0.38 (1.06%)

NASDAQ:1.26%
Market closed | Prices delayed by at least 15 minutes
Sell:$35.44
Buy:$35.50
Change:$0.38 (1.06%)
Deal now
Market closed | Prices delayed by at least 15 minutes
Sell:$35.44
Buy:$35.50
Change:$0.38 (1.06%)
Market closed | Prices delayed by at least 15 minutes
Deal now

Company Information

About this company

Simulations Plus, Inc. is a provider in the biopharma sector, offering advanced software and consulting services that enhance drug discovery, development, research, clinical trial operations, regulatory submissions, and commercialization. It operates through two segments: software and services. The Company’s business units include cheminformatics, physiologically based pharmacokinetics, clinical pharmacology and pharmacometrics, quantitative systems pharmacology, adaptive learning & insights and medical communications. The Company operates in biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry. It delivers simulation-enabled performance and intelligence solutions alongside medical communications support for clinical and commercial drug development. Its cutting-edge technology is licensed and utilized by pharmaceutical, biotechnology, and regulatory agencies worldwide.

Key people

Shawn M. O'Connor
Chief Executive Officer
William Frederick
Chief Financial Officer, Chief Operating Officer, Corporate Secretary
Murry Alper
President - Medical Communications
Steven Chang
President - Quantitative Systems Pharmacology Solutions
Jonathan Chauvin
Co-President - Clinical Pharmacology and Pharmacometric Services
John A. Dibella
President - PBPK and Cheminformatics Solutions
Jill Fiedler-Kelly
Co-President - Clinical Pharmacology and Pharmacometric Services
Jenna Rouse
Chief Markets Officer - Clinical Division of Pro-Ficiency
Daniel Szot
Chief Revenue Officer
Daniel L. Weiner
Non-Executive Chairman of the Board
Sharlene Evans
Independent Director
Lisa Lavange
Independent Director
John Kenneth Paglia
Independent Director
Walter S. Woltosz
Independent Director
Click to see more

Key facts

  • EPIC
    SLP
  • Location
    United States
  • Sector
    Technology
  • Industry
    Software & Programming
  • ISIN
    US8292141053
  • Market cap
    $713.94m
  • Employees
    243
  • Shares in issue
    20.11m
  • Exchange
    NASDAQ
  • Index
    S&P 600 Small Cap, TR Equity United States Index
  • Website
    Visit website

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.